XTL Biopharmaceuticals Ltd. (FRA:H2K2)
Germany · Delayed Price · Currency is EUR 0.5200
-0.0150 (-2.80%)
At close: Jan 9, 2026
XTL Biopharmaceuticals Market Cap
XTL Biopharmaceuticals has a market cap or net worth of €5.68 million as of January 9, 2026. Its market cap has decreased by -73.90% in one year.
Market Cap
5.68M
Enterprise Value
5.52M
Revenue
824.25K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.52
Market Cap Chart
Since August 30, 2005, XTL Biopharmaceuticals's market cap has decreased from 144.96M to 5.68M, a decrease of -96.08%. That is a compound annual growth rate of -14.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 5.68M | -6.43% |
| Dec 31, 2025 | 6.07M | -71.94% |
| Dec 31, 2024 | 21.62M | 351.29% |
| Dec 31, 2023 | 4.79M | -19.50% |
| Dec 29, 2022 | 5.95M | -55.04% |
| Dec 30, 2021 | 13.24M | 3.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.94B |
| Allianz SE | 148.37B |
| Deutsche Telekom AG | 134.57B |
| Siemens Energy AG | 105.59B |
| Rheinmetall AG | 84.93B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.49B |
| Deutsche Bank Aktiengesellschaft | 63.01B |